Biotransformation of terodiline. III. Opposed stereoselectivity in the benzylic and aromatic hydroxylations in rat liver microsomes

References

• Ariëns E. J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. European Journal of Clinical Pharmacology 1984; 26: 663–668
   PubMed Web of Science ®Google Scholar
• Von Bahr C., Hermansson J., Lindh M. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1982; 222: 458–462
   Google Scholar
• Benthe H. F., Thieme R. A. Identification of fendiline metabolites in human urine. Biomedical Mass Spectrometry 1983; 10: 65–73
   PubMedGoogle Scholar
• Brötell H., Sandqvist S. Determination of terodiline in serum and urine by gas chromatography with nitrogen detection. KabiVitrum AB, Stockholm 1983, Technical Report 83 98 056
   Google Scholar
• Carlström D., Hackzell I. Structure and absolute Configuration of N-tert-Butyl-1-methyl-3,3-diphenylpropylamine (Terodiline) Hydrochloride, C20H28N;.C1-. Acta Crystallographica Section C 1983; 39: 1130–1132
   Google Scholar
• Cho A. K., Lindeke B., Sum C. Y. The N-Hydroxylation of Phentermine (2-Methyl-2-Amino-1-Phenylpropane). Properties of the enzyme system. Drug Metabolism and Disposition 1974; 2: 1–8
   PubMed Web of Science ®Google Scholar
• Ekman G., Andersson K -E., Rud T., Ulmsten U. A double-blind, cross-over study of the effects of terodiline in women with unstable bladder. Acta Pharmacologica et Toxicologica 1980; 46(Suppl. I)39–43
   PubMedGoogle Scholar
• Evans G. M., Wilkinson G. R., Shand D. G. The Disposition of Propranolol IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver. Journal of Pharmacology and Experimental Therapeutics 1973; 186: 447–454
   PubMed Web of Science ®Google Scholar
• Geiger P. J., Bessman S. P. Protein determination by Lowry's methods in the presence of sulfhydryl reagents. Analytical Biochemistry 1972; 49: 467–473
   PubMed Web of Science ®Google Scholar
• Gunne L. M. The urinary output of d- and l-amphetamine in man. Biochemical Pharmacology 1967; 16: 863–869
   PubMed Web of Science ®Google Scholar
• Hammar G. G., Pettersson G., Carpenter P. T. Computerized mass fragmentography and peak matching. Biomedical Mass Spectrometry 1974; 1: 397–411
   PubMedGoogle Scholar
• Husted S., Andersson K -E., Sommer L., Østergaard J. R. Anticholinergic and calcium antagonistic effects of terodiline in rabbit urinary bladder. Acta Pharmacologica et Toxicologica 1980; 46(Suppl. I)20–30
   Google Scholar
• Miyano K., Fujii Y., Toki S. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes. Drug Metabolism and Disposition 1980; 8: 104–110
   PubMed Web of Science ®Google Scholar
• Murphy P. J., Williams T. L., Smallwood J. K., Bellamy G., Molloy B. B. Stereoselectivity in the metabolism of drobuline (dl-1-(isopropylamino)-4,4-diphenyl-2-butanol) a new anti-arrythmic agent. Life Sciences 1978; 23: 301–312
   Google Scholar
• Norén B., Strömberg S., Ericsson Ö., Olsson J -I., Moses P. Biotransformation of terodiline I. Identification of metabolites in dog urine by mass spectrometry. Biomedical Mass Spectrometry 1985a; 12: 367–379
   PubMedGoogle Scholar
• Norén B., Strömberg S., Ericsson Ö., Vangbo B., Grälls M., Widund L., Lindeke B. Biotransformation of terodiline II. Identification of metabolites in rat urine and rat liver microsomes by mass spectrometry. Acta Pharmaceutica Suecica 1985b; 22: 131–146
   PubMedGoogle Scholar
• Pohl L. R., Nelson S. D., Porter W. R., Trager W. F., Fasco M. J., Baker F. D., Fenton J. W., II. Warfarin—stereochemical aspects of its metabolism by rat liver microsomes. Biochemical Pharmacology 1976; 25: 2153–2162
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Porter W. R., Trager W. I. Stereochemical biotransformation of warfarin as a probe of the homogeneity and mechanism of microsomal hydroxylases. Biochemical Pharmacology 1977; 26: 109–114
   PubMed Web of Science ®Google Scholar
• Remberg G., Eichelbaum M., Spiteller G., Dengler H. J. Metabolism of DL- 14C - prenylamine in man. Biomedical Mass Spectrometry 1977; 4: 297–304
   PubMedGoogle Scholar
• Rud T., Andersson K -E., Boye N., Ulmsten U. Terodiline inhibition of human bladder contraction. Effects in vitro and in women with unstable bladder. Acta Pharmacologica et Toxicologica 1980; 46(Suppl. I)31–38
   Google Scholar
• Topham J. C. Relation between difference spectra and metabolism. Barbiturates, drug interaction, and species difference. Biochemical Pharmacology 1970; 19: 1965–1701
   Google Scholar
• Yacobi A., Levy G. Comparative pharmacokinetics of coumarin anticoagulants. XII. Pharmacokinetics of the warfarin enantiomers in rats. Journal of Pharmacokinetics and Biopharmaceuticals 1974; 2: 239–255
   PubMedGoogle Scholar